White-to-brown metabolic conversion of human adipocytes by JAK inhibition
View/ Open
Author
Moisan, Annie
Lee, Youn-Kyoung
Zhang, Jitao David
Meyer, Claas A.
Prummer, Michael
Zoffmann, Sannah
Truong, Hoa Hue
Ebeling, Martin
Kiialainen, Anna
Gérard, Régine
Schinzel, Robert T.
Amrein, Kurt E.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/ncb3075Metadata
Show full item recordCitation
Moisan, A., Y. Lee, J. D. Zhang, C. S. Hudak, C. A. Meyer, M. Prummer, S. Zoffmann, et al. 2014. “White-to-brown metabolic conversion of human adipocytes by JAK inhibition.” Nature cell biology 17 (1): 57-67. doi:10.1038/ncb3075. http://dx.doi.org/10.1038/ncb3075.Abstract
The rising incidence of obesity and related disorders such as diabetes and heart disease has focused considerable attention on the discovery of novel therapeutics. One promising approach has been to increase the number or activity of brown-like adipocytes in white adipose depots, as this has been shown to prevent diet-induced obesity and reduce the incidence and severity of type 2 diabetes. Thus, the conversion of fat-storing cells into metabolically active thermogenic cells has become an appealing therapeutic strategy to combat obesity. Here, we report a screening platform for the identification of small molecules capable of promoting a white-to-brown metabolic conversion in human adipocytes. We identified two inhibitors of Janus Kinase (JAK) activity with no precedent in adipose tissue biology that stably confer brown-like metabolic activity to white adipocytes. Importantly, these metabolically converted adipocytes exhibit elevated UCP1 expression and increased mitochondrial activity. We further found that repression of interferon signalling and activation of hedgehog signalling in JAK-inactivated adipocytes contributes to the metabolic conversion observed in these cells. Our findings highlight a novel role for the JAK/STAT pathway in the control of adipocyte function and establish a platform to identify compounds for the treatment of obesity.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276482/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:17820646
Collections
- FAS Scholarly Articles [18292]
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)